Shi L, Wang Y, Wang Y-D, Duan G-C, Yang H-Y
Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8576-8579. doi: 10.26355/eurrev_202008_22655.
This study aims to investigate the association between D-dimer and the risk of mortality in coronavirus disease 2019 (COVID-19) patients using a meta-analysis. We found that the D-dimer levels in non-survival patients were significantly higher than those in survival patients (SMD = 0.91, 95% CI = 0.79 to 1.03). In conclusion, the elevated D-dimer levels were associated with an increased risk of mortality in COVID-19 patients.
本研究旨在通过荟萃分析探讨D-二聚体与2019冠状病毒病(COVID-19)患者死亡风险之间的关联。我们发现,非存活患者的D-二聚体水平显著高于存活患者(标准化均数差=0.91,95%置信区间=0.79至1.03)。总之,D-二聚体水平升高与COVID-19患者死亡风险增加有关。